Yuekun Qi

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Yuekun Qi, Mingfeng Zhao, Yongxian Hu et al. · Blood · 2022 · 98 citations · Full text

Medicine, Hematology, Oncology +15

Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial

Jieyun Xia, Hujun Li, Zhiling Yan et al. · Journal of Clinical Oncology · 2023 · 90 citations · Full text

Medicine, Immunology, Oncology +17

Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment

Zhiling Yan, Huan-Xin Zhang, Jiang Cao et al. · Frontiers in Immunology · 2021 · 86 citations · Full text

Medicine, Hematology, Immunology +17

Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome

Yuekun Qi, Xiao Li, Chunkang Chang et al. · Scientific Reports · 2017 · 53 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Identification of influential parameters through sensitivity analysis of the TOUGH + Hydrate model using LH-OAT sampling

Junyi Huang, Jun Xu, Zhen Xia et al. · Marine and Petroleum Geology · 2015 · 21 citations

Engineering, Materials Engineering, Materials Science +11